Price $8.84 |
Market Cap
31.5M
|
Sector Health Care |
Div. Growth
-100.00%
|
|
P/E
-
|
P/B
3.39
|
P/S
103.0
|
Dividend %
0.40%
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-1.3K
|
FCF
-0.2
|
|
Op. Margin
-4.90%
|
Net Margin
-206.00%
|
ROE
-6.50%
|
ROI
1.90%
|
|
ROA
-4.70%
|
EPS Growth
91.60%
|
Current Ratio
-
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Celexus Inc (CXUS) | $1.60 | - | - | 5.2M | Strong Buy |
| MTBC Inc (MTBC) | $4.83 | - | - | 58.7M | Strong Buy |
| PDL BioPharma Inc (PDLI) | $2.91 | - | - | 355.9M | Strong Buy |
| Esperion Therapeutics Inc (ESPR) | $49.17 | - | - | 1.31B | Strong Buy |
| Premier Inc (PINC) | $37.02 | - | - | 4.68B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
